6533b7d4fe1ef96bd1262710
RESEARCH PRODUCT
Ramucirumab in patients with advanced hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): An exposure-response analysis
Yanzhi HsuMasatoshi KudoT. BergRichard S. FinnWilliam R. SchelmanAndrew X. ZhuY-k. KangJosep M. LlovetPeter R. GalleC.-j. YenKun LiangTakuji OkusakaLing GaoC.-h. HsuMasafumi IkedaKenta MotomuraRyan C. WidauEric AssenatL. O’briensubject
Sorafenibmedicine.medical_specialtyElevated alpha-fetoproteinbusiness.industryHematologymedicine.diseaseGastroenterologyRamucirumabInterval dataOncologyInternal medicineHepatocellular carcinomaMedicineIn patientProgression-free survivalbusinessExposure responsemedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2019-10-01 | Annals of Oncology |